L Buee

Summary

Country: France

Publications

  1. ncbi request reprint Brain microvascular changes in Alzheimer's disease and other dementias
    L Buee
    INSERM U422, Lille, France
    Ann N Y Acad Sci 826:7-24. 1997
  2. ncbi request reprint Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
    L Buee
    INSERM U422, F 59045 Lille, France
    Brain Pathol 9:681-93. 1999
  3. ncbi request reprint Proteasome inhibition and Tau proteolysis: an unexpected regulation
    P Delobel
    INSERM U422, Institut de Médecine Prédictive et Recherche Thérapeutique, Place de Verdun, 59045, Lille, France
    FEBS Lett 579:1-5. 2005
  4. ncbi request reprint Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation
    C Mailliot
    INSERM U422, Lille, France
    Neurosci Lett 255:13-6. 1998
  5. ncbi request reprint Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
    L Buee
    INSERM U422, Place de Verdun, 59045 Cedex, Lille, France
    Brain Res Brain Res Rev 33:95-130. 2000
  6. ncbi request reprint Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
    K Belarbi
    Universite Lille Nord de France, Lille, France
    Curr Alzheimer Res 8:633-8. 2011
  7. ncbi request reprint Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities
    P Delobel
    INSERM U422, IMPRT, Institut de Médecine Prédictive et Recherche Thérapeutique, Place de Verdun, 59045, Lille, France
    FEBS Lett 516:151-5. 2002
  8. doi request reprint Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors
    K Lécolle
    INSERM, UMR837, rue Polonovski, Lille, France
    Gene Ther 20:283-97. 2013
  9. doi request reprint Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing
    C M Dhaenens
    INSERM, U837 1, Alzheimer and Tauopathies, Place de Verdun, F 59045 Lille, France
    Biochim Biophys Acta 1812:732-42. 2011

Collaborators

  • A Delacourte
  • M L Caillet-Boudin
  • P Delobel
  • P R Hof
  • V Prevot
  • K Schindowski
  • D Blum
  • K Lécolle
  • D Demeyer
  • R Caillierez
  • K Belarbi
  • C M Dhaenens
  • J C Beauvillain
  • J P Lejeune
  • A Loyens
  • E Grellier
  • M Baroncini
  • M Colin
  • P Dournaud
  • A Sharif
  • J C D'Halluin
  • S Begard
  • Z Csaba
  • S Burnouf
  • B Sablonniere
  • J Desmercières
  • A Sistiaga
  • F Fernandez-Gomez
  • M Hamdane
  • N Charlet-Berguerand
  • L Tsambou
  • E Van Brussels
  • H Obriot
  • S Schraen-Maschke
  • S Eddarkaoui
  • L Troquier
  • F J Fernandez-Gomez
  • M L Frandemiche
  • J Brouillette
  • A Lopez de Munain
  • H Tran
  • M H Gevaert
  • V Deramecourt
  • C Carpentier
  • N Sergeant
  • M E Grosjean
  • M Goicoechea
  • C A Maurage
  • A Labudeck
  • C Mailliot
  • T Bussiere

Detail Information

Publications9

  1. ncbi request reprint Brain microvascular changes in Alzheimer's disease and other dementias
    L Buee
    INSERM U422, Lille, France
    Ann N Y Acad Sci 826:7-24. 1997
    ..This aspect of pathology is particularly interesting in view of its accessibility to therapeutic interventions...
  2. ncbi request reprint Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
    L Buee
    INSERM U422, F 59045 Lille, France
    Brain Pathol 9:681-93. 1999
    ..Thus, tau mutations and polymorphisms may also be instrumental in many neurodegenerative disorders...
  3. ncbi request reprint Proteasome inhibition and Tau proteolysis: an unexpected regulation
    P Delobel
    INSERM U422, Institut de Médecine Prédictive et Recherche Thérapeutique, Place de Verdun, 59045, Lille, France
    FEBS Lett 579:1-5. 2005
    ..Surprisingly, we showed that the inhibition of the proteasome led to a bidirectional degradation of Tau. Following this result, the cellular mechanisms that may degrade Tau were investigated...
  4. ncbi request reprint Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation
    C Mailliot
    INSERM U422, Lille, France
    Neurosci Lett 255:13-6. 1998
    ..This represents a useful model to study abnormal tau phosphorylation in situ...
  5. ncbi request reprint Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
    L Buee
    INSERM U422, Place de Verdun, 59045 Cedex, Lille, France
    Brain Res Brain Res Rev 33:95-130. 2000
    ....
  6. ncbi request reprint Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?
    K Belarbi
    Universite Lille Nord de France, Lille, France
    Curr Alzheimer Res 8:633-8. 2011
    ..Finally, our data strongly support that tau pathology could be instrumental in the cholinergic neuronal loss observed in AD...
  7. ncbi request reprint Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities
    P Delobel
    INSERM U422, IMPRT, Institut de Médecine Prédictive et Recherche Thérapeutique, Place de Verdun, 59045, Lille, France
    FEBS Lett 516:151-5. 2002
    ..Our results demonstrate that a non-modified physiological process in a cell model can generate the most specific Alzheimer epitope of Tau pathology...
  8. doi request reprint Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors
    K Lécolle
    INSERM, UMR837, rue Polonovski, Lille, France
    Gene Ther 20:283-97. 2013
    ..Adenoviral vectors targeting SRIF receptors might thus represent a promising therapeutic approach to brain tumors...
  9. doi request reprint Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing
    C M Dhaenens
    INSERM, U837 1, Alzheimer and Tauopathies, Place de Verdun, F 59045 Lille, France
    Biochim Biophys Acta 1812:732-42. 2011
    ....